Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/1999
11/04/1999CA2330644A1 Solution containing nicotine
11/04/1999CA2330577A1 Serotonergic agents
11/04/1999CA2330576A1 Substituted benzazocines as nicotine-binding inhibitors
11/04/1999CA2330458A1 Methods of identifying and using hla binding compounds as hla-agonists and antagonists
11/04/1999CA2330452A1 Antipsychotic indolyl derivatives
11/04/1999CA2330437A1 Indolyl derivatives as serotonergic agents
11/04/1999CA2330436A1 Indolyl derivatives as serotonergic agents
11/04/1999CA2330055A1 Paroxetine ascorbate
11/04/1999CA2329913A1 Paroxetine 10-camphorsulfonate for treatment of cns disorders
11/04/1999CA2329709A1 Compounds and methods for treating mitochondria-associated diseases
11/04/1999CA2328929A1 Serotonin potentiation by oleamide analogs
11/04/1999CA2328778A1 Process for the preparation of tetralone imines for the preparation of active pharmaceutical compounds
11/04/1999CA2328111A1 Compositions and methods for extending the action of clostridial neurotoxin
11/04/1999CA2327504A1 Cd40-interacting and traf-interacting proteins
11/04/1999CA2326233A1 Delayed rectifier potassium channel subunit
11/03/1999EP0953641A2 Polynucleotide molecules encoding neospora proteins
11/03/1999EP0953637A2 Acetylcholine receptor
11/03/1999EP0953636A2 Cytokine signal regulators
11/03/1999EP0953576A1 Active hedgehog protein conjugate, process for its production and use
11/03/1999EP0953567A2 Bicyclic substituted piperazine-, piperidine- and tetrahydropyridine derivatives, their preparation and their use as agents with central dopaminergic (dopamine D4 receptor) activity
11/03/1999EP0952844A1 USE OF PROTEIN S-100b IN MEDICINES AND MEDICINES CONTAINING THE PROTEIN S-100b
11/03/1999EP0952831A1 Paroxetine compositions
11/03/1999EP0952772A1 Compositions and methods of use of mononuclear phagocytes to promote axonal regeneration
11/03/1999EP0754033B1 Heterofunctional, mucoadhesive dosage form
11/03/1999EP0744944B1 Sexual steroid-containing transdermal therapeutic systems
11/03/1999EP0728129B1 Novel phenylalkylaminoalcohol carbamates and process for preparing the same
11/03/1999CN1234039A 3-mercaptoacetylamino-1,5-subsd. 2-oxo-azepon derivatives useful as inhibitor of metrix metalloproteinase
11/03/1999CN1234038A C-end modified (N-subsd.)-2-indyldipeptide used for ICE/ced-3 family cysteine protein enzyme inhibitor
11/03/1999CN1234037A Subsd. aminoalkane phosphonic acids
11/03/1999CN1234033A 4-aminoethyoxy-indolone derivatives as dopamine D2 agonists
11/03/1999CN1234031A Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the prodn. of tumor necrosis factor (TNF)
11/03/1999CN1234026A Piperazino derivatives as neurokinin antagonists
11/03/1999CN1234025A 1-phenyl-benzimidazole compounds and their use as BAGA-A receptor modulator
11/03/1999CN1234024A 4-aminoethoxy indolone derivatives
11/03/1999CN1234023A 4-aminoethoxy indoes as dopamin D2 agonists and as 5HT1A ligands
11/03/1999CN1233955A Pharmaceutical prepn. comprising eicosapentaenoic acid and/or stearidonic acid
11/03/1999CN1233616A Active hedgehog protein conjugate, process for its prodn. and use
11/03/1999CN1233468A Pharmaceutical composition comprising bisphosphonic acid
11/02/1999USRE36375 Treatment of Alzheimer's disease using azacyclic compounds
11/02/1999USRE36374 1,2,3-triazole and tetrazole substituted piperidine or tetrahydropyridine compounds useful as acetylcholine agonists
11/02/1999US5977367 N-aminoalkyldibenzofurancarboxamides; new dopamine receptor subtype specific ligands
11/02/1999US5977359 Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present
11/02/1999US5977311 53BP2 complexes
11/02/1999US5977150 Amino acid derivatives of diaryl 1,3,4-oxadiazolone
11/02/1999US5977144 Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
11/02/1999US5977142 Oxa-and thia-diazole muscarinic receptor antagonists
11/02/1999US5977140 N-[(4-Heteroaryl-1-Piperidinyl)Alkly] Phthalimides and related compounds and their therapeutic utility
11/02/1999US5977135 Bicyclic heterocycles
11/02/1999US5977131 Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents
11/02/1999US5977129 Alzheimer's disease
11/02/1999US5977124 β-adrenergic agonists
11/02/1999US5977119 Trisubstituted thioxanthines
11/02/1999US5977113 4-heteroaryl-1-piperazine alkylamines and their therapeutic utility
11/02/1999US5977112 Process of making substituted benzofurans
11/02/1999US5977107 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists
11/02/1999US5977106 3,5-dioxo-(2H,4H)-1,2,4-triazine derivatives
11/02/1999US5977103 Substituted imidazole compounds
11/02/1999US5977099 Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
11/02/1999US5976834 cDNA clone HNFJD15 that encodes a novel human 7-transmembrane receptor
11/02/1999US5976815 Screening drugs/ligands of activin receptor-like kinase 7 receptor by transfecting host cell with nucleic acid encoding receptor protein, contacting cell with drug/ligand, evaluating effect on kinase activity
11/02/1999US5976814 DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
10/1999
10/30/1999CA2269221A1 Active hedgehog protein conjugate, process for its production and use
10/28/1999WO1999054463A2 Human k+ ion channel and therapeutic applications thereof
10/28/1999WO1999054351A1 Edg family gene, human h218
10/28/1999WO1999054350A1 Novel omega conotoxin peptides
10/28/1999WO1999054336A1 (alpha-aminophosphino) peptidesderivative and compositions containing same
10/28/1999WO1999054333A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
10/28/1999WO1999054331A1 Novel asymmetrically substituted xanthine derivatives, method for producing them and their use as medicaments with an adenosine-antagonistic effect
10/28/1999WO1999054320A1 Novel heterocyclically substituted amides with cysteine protease-inhibiting effect
10/28/1999WO1999054315A2 Triazolones with a neuroprotective action
10/28/1999WO1999054314A1 Novel diphenyl-substituted 5-ring-heterocycles, method for producing them and their use as medicaments
10/28/1999WO1999054311A1 Novel diphenyl-substituted 6-ring-heterocycles, methods for producing them and their use as medicaments
10/28/1999WO1999054310A2 New substituted amides, their production and their use
10/28/1999WO1999054305A1 Heterocyclically substituted amides used as calpain inhibitors
10/28/1999WO1999054304A1 Heterocyclically substituted amides, their production and their use
10/28/1999WO1999054302A1 Process for the production of r-(+)-6- carboxamido- 3-n- methylamino- 1,2,3,4- tetrahydrocarbazole
10/28/1999WO1999054294A1 New substituted amides, their production and their use
10/28/1999WO1999054293A1 Substituted benzamides, their production and their use as cysteine protease inhibitors
10/28/1999WO1999054280A1 Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation
10/28/1999WO1999053959A2 Use of viral vectors for treatment of the injured peripheral and central nervous system
10/28/1999WO1999053951A1 Terminally-branched polymeric linkers and polymeric conjugates containing the same
10/28/1999WO1999053945A1 Neuron growth inhibitory molecules or derivatives thereof used to immunize mammals thereby promoting axon regeneration
10/28/1999WO1999053943A2 Therapeutic angiogenic factors and methods for their use
10/28/1999WO1999053935A1 Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga
10/28/1999WO1999053921A1 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
10/28/1999WO1999053919A1 Treatment of generalized anxiety disorder with paroxetine
10/28/1999WO1999053917A1 Cannabinoids as antioxidants and neuroprotectants
10/28/1999WO1999053899A1 Medicinal compositions for application to mucosa
10/28/1999WO1999042089A9 Use of thiadiazolo[4,3-a]pyridine derivatives
10/28/1999WO1999040946A3 Methods and compositions for modulating leptin activity
10/28/1999WO1999040112A9 Neuroprotective peptides and uses thereof
10/28/1999WO1999021540B1 Method of reducing craving in mammals
10/28/1999WO1999005272A9 Use of transcription factor brn-3a
10/28/1999WO1997029739A3 Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors
10/28/1999CA2329637A1 (alpha-aminophosphino) peptidesderivative and compositions containing same
10/28/1999CA2329626A1 Cannabinoids as antioxidants and neuroprotectants
10/28/1999CA2329010A1 Therapeutic angiogenic factors and methods for their use
10/28/1999CA2328896A1 Treatment of generalized anxiety disorder with paroxetine
10/28/1999CA2328720A1 Novel heterocyclically substituted amides with cysteine protease-inhibiting effect
10/28/1999CA2328435A1 New substituted amides, their production and their use
1 ... 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 ... 1833